Evidence map›Paper›PMID 29584635›Full record

ArticleMolecules (Basel, Switzerland)2018

The Synthesis of Molecular Docking Studies, In Vitro Antimicrobial and Antifungal Activities of Novel Dipeptide Derivatives Based on N-(2-(2-Hydrazinyl-2-oxoethylamino)-2-oxoethyl)-nicotinamide.

Gaber Moustafa, Hemat Khalaf, Ahmed Naglah, Asma Al-Wasidi, Nawal Al-Jafshar, Hassan Awad

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. NDrug design, development and therapy · 2021
    Article
  7. Article
  8. Article
  9. Journal of enzyme inhibition and medicinal chemistry · 2019
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gaber MoustafaPeptide Chemistry Department, Chemical Industries Research Division, National Research Centre, Dokki 12622, Cairo, Egypt. gosman79@gmail.com.ORCID 0000-0002-2489-8228
Hemat KhalafChemistry Department, College of Science and Arts-Qurayat, Jouf University, Sakaka 72388, Saudi Arabia. hematsalama2016@gmail.com.
Ahmed NaglahPeptide Chemistry Department, Chemical Industries Research Division, National Research Centre, Dokki 12622, Cairo, Egypt. amnaglah@gmail.com.
Asma Al-WasidiDepartment of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia. asmachem7@hotmail.com.
Nawal Al-JafsharDepartment of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia. Nawal.Aljafshar@hotmail.com.
Hassan AwadChemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Div., National Research Centre, Dokki 12622, Cairo, Egypt. awadmhassan@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of linear dipeptide derivatives (

Indexed as

Anti-Bacterial AgentsAntifungal AgentsCandida albicansCatalytic DomainDipeptidesDrug DesignEscherichia coliEscherichia coli ProteinsFatty Acid DesaturasesFungal ProteinsMicrobial Sensitivity TestsModels, MolecularMolecular Docking SimulationNiacinamideSterol 14-DemethylaseStructure-Activity RelationshipAnti-Bacterial AgentsAntifungal AgentsDipeptidesEscherichia coli ProteinsFatty Acid DesaturasesFungal ProteinsNiacinamideSterol 14-Demethylaseamino acidsantimicrobial activitylinear dipeptidesmolecular docking studiesnicotinoyl chloride

Identifiers

PMID29584635
PMCPMC6017860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.